Study
Nutriventia Unveils New Study Results for Sustained-Release Melotime™ Melatonin: Prolonged Plasma Levels with One Dose
Nutriventia, a pioneer in consumer-centric nutraceutical innovations, has announced the results of a new pharmacokinetic study evaluating its novel Melotime™ sustained-release melatonin designed to support healthy sleep patterns. According to Dr. Shefali Thanawala, Head of Medical Science and Research, the study demonstrates the unique benefits of Nutriventia’s advanced delivery technology,
December 19, 2024
No Comments
